m+Medelevator.RU
← Поиск публикаций
International journal of surgery case reports · 2026

Fibrocystic disease within an axillary accessory breast (Kajava class IV): a case report.

Клинический случайСтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Al-Ahmar Rawan, Haj Osman Osama, Ghabreau Lina, Ayoub Kusay

Аннотация

INTRODUCTION: Accessory breast tissue is a congenital anomaly occurring in 0.4-6% of the population, most commonly in the axilla. While this tissue is subject to the same physiological and pathological changes as orthotopic breast tissue, fibrocystic disease presenting as a large axillary mass is rare, representing a diagnostic challenge that mimics lipomas and other conditions common in the axillary region.

CASE PRESENTATION: We report a case of 33-year-old female who presented with a chronic painful mass in the left axilla that have been present for 10 years. Clinical examination revealed a soft, mobile mass without associated nipple or areola (Kajava Class IV). Initially suspected to be a lipoma, ultrasonography suggested ectopic breast tissue. Excisional biopsy was performed, revealing a mass of size 9 × 8.5 x 3.5 cm. Histopathological analysis confirmed benign mammary parenchyma with prominent fibrocystic changes, including ductal ectasia and apocrine metaplasia. The patient showed satisfactory recovery with no recurrence at the 1-month follow-up.

DISCUSSION: This case emphasizes the importance of including accessory breast tissue in the differential diagnosis of axillary swellings, even when clinical features suggest more common benign lesions like lipomas.

CONCLUSION: Early recognition through clinical suspicion, imaging, and histopathological confirmation is crucial, particularly in low-resource settings, to ensure appropriate management and monitor for potential neoplastic transformation.

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты